Overview
46,XY difference of sexual development (DSD) due to a dihydrotestosterone (DHT) backdoor pathway biosynthesis defect is a rare hormonal condition that affects how the body produces a powerful form of the male sex hormone called dihydrotestosterone (DHT). In people with this condition, a specific chemical shortcut — called the 'backdoor pathway' — that the body normally uses to make DHT during fetal development does not work properly. DHT plays a critical role in shaping the external genitalia before birth in babies with XY chromosomes. When DHT levels are too low during pregnancy, the genitalia may not develop in the typical male pattern, leading to what doctors call 'undervirilization.' This means the external genitalia may appear somewhere between typical male and female, or may look more female than expected at birth. This condition is sometimes referred to as a backdoor pathway DHT deficiency or a disorder of sex development related to androgen biosynthesis. The defect is caused by changes (variants) in specific genes that control enzymes involved in this backdoor hormone-making process. Key symptoms include ambiguous genitalia at birth, undescended testes, a small or atypically formed penis, and in some cases, a urethral opening in an unusual position (hypospadias). Hormone levels in blood tests may show abnormal ratios of certain steroids. Treatment is highly individualized and may include hormone therapy, surgical procedures to correct genital anatomy, and long-term psychological and endocrine support. A team of specialists works together to support the child and family through diagnosis, gender assignment decisions, and ongoing care. Early diagnosis is important for the best possible outcomes.
Also known as:
Key symptoms:
Ambiguous genitalia at birth — external sex organs that do not look clearly male or femaleUndescended testes (one or both testes not in the scrotum)Unusually small penis (micropenis)Hypospadias — the urethral opening is on the underside of the penis rather than at the tipPartially fused or underdeveloped scrotal tissueLow levels of DHT detected on hormone blood testsAbnormal ratios of certain steroid hormones in urine or bloodPossible reduced body or facial hair development during pubertyPossible incomplete masculinization at pubertyInfertility or reduced fertility in adulthood
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for 46,XY difference of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for 46,XY difference of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for 46,XY difference of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to 46,XY difference of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect.
Community
No community posts yet. Be the first to share your experience with 46,XY difference of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect.
Start the conversation →Latest news about 46,XY difference of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect
No recent news articles for 46,XY difference of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific gene change has been found in my child, and what does that mean for their health and development?,What hormone tests will be done regularly, and what results should I watch for?,Is surgery recommended, and if so, when and what are the risks and benefits of waiting versus acting now?,What hormone therapy options are available, and when might they be needed?,How can I best support my child's emotional wellbeing and sense of identity as they grow up?,Are there other family members who should be tested for this gene change?,Are there patient support groups or DSD specialist centers you can refer us to?
Common questions about 46,XY difference of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect
What is 46,XY difference of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect?
46,XY difference of sexual development (DSD) due to a dihydrotestosterone (DHT) backdoor pathway biosynthesis defect is a rare hormonal condition that affects how the body produces a powerful form of the male sex hormone called dihydrotestosterone (DHT). In people with this condition, a specific chemical shortcut — called the 'backdoor pathway' — that the body normally uses to make DHT during fetal development does not work properly. DHT plays a critical role in shaping the external genitalia before birth in babies with XY chromosomes. When DHT levels are too low during pregnancy, the genitali
How is 46,XY difference of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect inherited?
46,XY difference of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does 46,XY difference of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect typically begin?
Typical onset of 46,XY difference of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect is neonatal. Age of onset can vary across affected individuals.